Federal health regulators have signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years.
Adding apalutamide to ADT in the adjuvant and neoadjuvant settings improves outcomes in prostate cancer patients undergoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results